Lotus Pharmaceuticals Valuation

LTUS Stock  USD 0.0009  0.0001  12.50%   
Lotus Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Lotus Pharmaceuticals from analyzing the firm fundamentals such as Current Valuation of 762.17 K, return on equity of 0.0182, and Profit Margin of 0.02 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.0009
Please note that Lotus Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of Lotus Pharmaceuticals is based on 3 months time horizon. Increasing Lotus Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lotus pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Lotus Pharmaceuticals. Since Lotus Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lotus Pink Sheet. However, Lotus Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  9.0E-4 Real  8.64E-4 Hype  6.9E-4
The intrinsic value of Lotus Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lotus Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.0009
Real Value
46.52
Upside
Estimating the potential upside or downside of Lotus Pharmaceuticals helps investors to forecast how Lotus pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lotus Pharmaceuticals more accurately as focusing exclusively on Lotus Pharmaceuticals' fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.000.000746.52
Details

Lotus Pharmaceuticals Total Value Analysis

Lotus Pharmaceuticals is now anticipated to have valuation of 762.17 K with market capitalization of 834.49 K, debt of 5.24 M, and cash on hands of 158.91 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Lotus Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
762.17 K
834.49 K
5.24 M
158.91 K

Lotus Pharmaceuticals Investor Information

The company has price-to-book ratio of 0.01. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lotus Pharmaceuticals had not issued any dividends in recent years. The entity had 1:2 split on the 31st of December 0202. Based on the key indicators related to Lotus Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Lotus Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

Lotus Pharmaceuticals Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Lotus Pharmaceuticals has an asset utilization ratio of 70.45 percent. This implies that the Company is making $0.7 for each dollar of assets. An increasing asset utilization means that Lotus Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.

Lotus Pharmaceuticals Profitability Analysis

The company reported the previous year's revenue of 72.7 M. Net Income was 14.42 M with profit before overhead, payroll, taxes, and interest of 39.78 M.

About Lotus Pharmaceuticals Valuation

The pink sheet valuation mechanism determines Lotus Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Lotus Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lotus Pharmaceuticals. We calculate exposure to Lotus Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lotus Pharmaceuticals's related companies.
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the Peoples Republic of China. Lotus Pharmaceutical operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 233 people.

8 Steps to conduct Lotus Pharmaceuticals' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lotus Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lotus Pharmaceuticals' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Lotus Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Lotus Pharmaceuticals' revenue streams: Identify Lotus Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Lotus Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Lotus Pharmaceuticals' growth potential: Evaluate Lotus Pharmaceuticals' management, business model, and growth potential.
  • Determine Lotus Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lotus Pharmaceuticals' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Lotus Pharmaceuticals Growth Indicators

Investing in growth stocks can be very risky. If the company such as Lotus Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quarterly Earnings Growth Y O Y-0.822
Retained Earnings60.2 M

Additional Tools for Lotus Pink Sheet Analysis

When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.